Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer
Takahito Sugase(Thomas Jefferson University), Tetsuji Naka(National Institute of Biomedical Innovation, Health and Nutrition)
Cited by 28
Related Papers
The paradigm of IL-6: from basic science to medicine.
|Arthritis Research|2002|481
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis
|Inflammatory Bowel Diseases|2012|230
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma
|British Journal of Cancer|2016|135
SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases
|Gastroenterology Research and Practice|2010|118
Anti‐glypican‐1 antibody‐drug conjugate exhibits potent preclinical antitumor activity against glypican‐1 positive uterine cervical cancer
|International Journal of Cancer|2017|66